{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:25:52Z","timestamp":1792113952316,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13346-025-01837-5","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T16:31:11Z","timestamp":1743179471000},"page":"3258-3273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Optimized mucus adhesion and penetration of lipid-polymer nanoparticles enables effective nose-to-brain delivery of perillyl alcohol for glioblastoma therapy"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5634-3104","authenticated-orcid":false,"given":"Edilson Ribeiro","family":"de Oliveira Junior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4316-2266","authenticated-orcid":false,"given":"Jonathan Matheus","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8042-6209","authenticated-orcid":false,"given":"Mariana Arraes","family":"Salom\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9100-4165","authenticated-orcid":false,"given":"Nathalia Correa","family":"de Almeida Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1041-1375","authenticated-orcid":false,"given":"Carla Santos","family":"de Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5090-9971","authenticated-orcid":false,"given":"Nat\u00e1lia Noronha","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9276-1939","authenticated-orcid":false,"given":"Natalia Sanchez","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3429-3513","authenticated-orcid":false,"given":"Camila Fernanda","family":"Rodero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4997-2658","authenticated-orcid":false,"given":"Daniel","family":"Graziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4307-3077","authenticated-orcid":false,"given":"Valtencir","family":"Zucolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9545-5248","authenticated-orcid":false,"given":"Sebasti\u00e3o Ant\u00f4nio","family":"Mendanha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1231-5803","authenticated-orcid":false,"given":"Eliana Martins","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"1837_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.brainresbull.2022.09.017","volume":"190","author":"S Zhang","year":"2022","unstructured":"Zhang S, Gan L, Cao F, Wang H, Gong P, Ma C, et al. The barrier and interface mechanisms of the brain barrier, and brain drug delivery. Brain Res Bull. 2022;190:69\u201383. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.09.017.","journal-title":"Brain Res Bull"},{"key":"1837_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood\u2013brain barrier: structure, regulation and drug delivery. Signal Transduct Target Ther. 2023;8:217. https:\/\/doi.org\/10.1038\/s41392-023-01481-w.","journal-title":"Signal Transduct Target Ther"},{"key":"1837_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","volume":"195","author":"TP Crowe","year":"2018","unstructured":"Crowe TP, Greenlee MHW, Kanthasamy AG, Hsu WH. Mechanism of intranasal drug delivery directly to the brain. Life Sci. 2018;195:44\u201352. https:\/\/doi.org\/10.1016\/j.lfs.2017.12.025.","journal-title":"Life Sci"},{"key":"1837_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jconrel.2023.12.054","volume":"366","author":"Q Huang","year":"2024","unstructured":"Huang Q, Chen Y, Zhang W, Xia X, Li H, Qin M, et al. Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases. J Controlled Release. 2024;366:519\u201334. https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.054.","journal-title":"J Controlled Release"},{"key":"1837_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106282","volume":"101","author":"AM Martins","year":"2024","unstructured":"Martins AM, Palomba R, Schlich M, Decuzzi P. On the axonal transport of lipid nanoparticles in primary hippocampal neurons. J Drug Deliv Sci Technol. 2024;101: 106282. https:\/\/doi.org\/10.1016\/j.jddst.2024.106282.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1837_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ma14071802","volume":"14","author":"R Cassano","year":"2021","unstructured":"Cassano R, Servidio C, Trombino S. Biomaterials for drugs nose-brain transport: a new therapeutic approach for neurological diseases. Materials. 2021;14: 1802. https:\/\/doi.org\/10.3390\/ma14071802.","journal-title":"Materials"},{"key":"1837_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10010034","volume":"10","author":"F Sonvico","year":"2018","unstructured":"Sonvico F, Clementino A, Buttini F, Colombo G, Pescina S, Stanis\u00e7uaski Guterres S, et al. Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting. Pharmaceutics. 2018;10: 34. https:\/\/doi.org\/10.3390\/pharmaceutics10010034.","journal-title":"Pharmaceutics"},{"key":"1837_CR8","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.2147\/IJN.S452316","volume":"19","author":"A Bonaccorso","year":"2024","unstructured":"Bonaccorso A, Ortis A, Musumeci T, Carbone C, Hussain M, Di Salvatore V, et al. Nose-to-brain drug delivery and physico-chemical properties of nanosystems: analysis and correlation studies of data from scientific literature. Int J Nanomedicine. 2024;19:5619\u201336. https:\/\/doi.org\/10.2147\/IJN.S452316.","journal-title":"Int J Nanomedicine"},{"key":"1837_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1208\/s12249-024-02946-z","volume":"25","author":"M Butola","year":"2024","unstructured":"Butola M, Nainwal N. Non-invasive techniques of nose to brain delivery using nanoparticulate carriers: hopes and hurdles. AAPS PharmSciTech. 2024;25:256. https:\/\/doi.org\/10.1208\/s12249-024-02946-z.","journal-title":"AAPS PharmSciTech"},{"key":"1837_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11095-019-2662-z","volume":"36","author":"ER De Oliveira Junior","year":"2019","unstructured":"De Oliveira Junior ER, Nascimento TL, Salom\u00e3o MA, Da Silva ACG, Valadares MC, Lima EM. Increased nose-to-brain delivery of melatonin mediated by polycaprolactone nanoparticles for the treatment of glioblastoma. Pharm Res. 2019;36:131. https:\/\/doi.org\/10.1007\/s11095-019-2662-z.","journal-title":"Pharm Res"},{"key":"1837_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120714","volume":"603","author":"NN Ferreira","year":"2021","unstructured":"Ferreira NN, De Oliveira JE, Granja S, Boni FI, Ferreira LMB, Cury BSF, et al. Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system. Int J Pharm. 2021;603: 120714. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120714.","journal-title":"Int J Pharm"},{"key":"1837_CR12","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/17425247.2024.2339335","volume":"21","author":"T Hua","year":"2024","unstructured":"Hua T, Li S, Han B. Nanomedicines for intranasal delivery: understanding the nano-bio interactions at the nasal mucus-mucosal barrier. Expert Opin Drug Deliv. 2024;21:553\u201372. https:\/\/doi.org\/10.1080\/17425247.2024.2339335.","journal-title":"Expert Opin Drug Deliv"},{"key":"1837_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115196","volume":"207","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhang C, Huang Y, Ma Y, Song Q, Chen H, et al. Intranasal drug delivery: the interaction between nanoparticles and the nose-to-brain pathway. Adv Drug Deliv Rev. 2024;207: 115196. https:\/\/doi.org\/10.1016\/j.addr.2024.115196.","journal-title":"Adv Drug Deliv Rev"},{"key":"1837_CR14","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1021\/acsnano.2c11147","volume":"17","author":"Y Guo","year":"2023","unstructured":"Guo Y, Ma Y, Chen X, Li M, Ma X, Cheng G, et al. Mucus penetration of surface-engineered nanoparticles in various pH microenvironments. ACS Nano. 2023;17:2813\u201328. https:\/\/doi.org\/10.1021\/acsnano.2c11147.","journal-title":"ACS Nano"},{"key":"1837_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2021.102432","volume":"37","author":"NN Porfiryeva","year":"2021","unstructured":"Porfiryeva NN, Semina II, Salakhov IA, Moustafine RI, Khutoryanskiy VV. Mucoadhesive and mucus-penetrating interpolyelectrolyte complexes for nose-to-brain drug delivery. Nanomed Nanotechnol Biol Med. 2021;37: 102432. https:\/\/doi.org\/10.1016\/j.nano.2021.102432.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"1837_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106322","volume":"102","author":"M Qindeel","year":"2024","unstructured":"Qindeel M, Irfan M, Ullah S, Fathi-karkan S, Kharaba Z, Rahdar A, et al. Nanotechnology in glioblastoma therapy: advances in drug delivery systems and diagnostic approaches. J Drug Deliv Sci Technol. 2024;102: 106322. https:\/\/doi.org\/10.1016\/j.jddst.2024.106322.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1837_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22261","volume":"85","author":"S Satish","year":"2024","unstructured":"Satish S, Athavale M, Kharkar PS. Targeted therapies for Glioblastoma multiforme (GBM): state-of-the-art and future prospects. Drug Dev Res. 2024;85: e22261. https:\/\/doi.org\/10.1002\/ddr.22261.","journal-title":"Drug Dev Res"},{"key":"1837_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122167","volume":"13","author":"TC Chen","year":"2021","unstructured":"Chen TC, Da Fonseca CO, Levin D, Sch\u00f6nthal AH. The monoterpenoid perillyl alcohol: anticancer agent and medium to overcome biological barriers. Pharmaceutics. 2021;13: 2167. https:\/\/doi.org\/10.3390\/pharmaceutics13122167.","journal-title":"Pharmaceutics"},{"key":"1837_CR19","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1158\/1535-7163.MCT-12-0321","volume":"11","author":"H-Y Cho","year":"2012","unstructured":"Cho H-Y, Wang W, Jhaveri N, Torres S, Tseng J, Leong MN, et al. Perillyl alcohol for the treatment of temozolomide-resistant gliomas. Mol Cancer Ther. 2012;11:2462\u201372. https:\/\/doi.org\/10.1158\/1535-7163.MCT-12-0321.","journal-title":"Mol Cancer Ther"},{"key":"1837_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdab005","volume":"3","author":"AH Sch\u00f6nthal","year":"2021","unstructured":"Sch\u00f6nthal AH, Peereboom DM, Wagle N, Lai R, Mathew AJ, Hurth KM, et al. Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma. Neuro-Oncol Adv. 2021;3: vdab005. https:\/\/doi.org\/10.1093\/noajnl\/vdab005.","journal-title":"Neuro-Oncol Adv"},{"key":"1837_CR21","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1007\/s13346-020-00816-2","volume":"10","author":"ER De Oliveira Junior","year":"2020","unstructured":"De Oliveira Junior ER, Santos LCR, Salom\u00e3o MA, Nascimento TL, De Almeida Ribeiro Oliveira G, Li\u00e3o LM, et al. Nose-to-brain drug delivery mediated by polymeric nanoparticles: influence of PEG surface coating. Drug Deliv Transl Res. 2020;10:1688\u201399. https:\/\/doi.org\/10.1007\/s13346-020-00816-2.","journal-title":"Drug Deliv Transl Res"},{"key":"1837_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2022.101631","volume":"29","author":"ML Formica","year":"2022","unstructured":"Formica ML, Real DA, Picchio ML, Catlin E, Donnelly RF, Paredes AJ. On a highway to the brain: a review on nose-to-brain drug delivery using nanoparticles. Appl Mater Today. 2022;29: 101631. https:\/\/doi.org\/10.1016\/j.apmt.2022.101631.","journal-title":"Appl Mater Today"},{"key":"1837_CR23","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2147\/IJN.S400798","volume":"18","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhou P, Jiang Y, Li L, Ju F, Cheng Q, et al. Sustained-release esketamine based nanoparticle-hydrogel delivery system for neuropathic pain management. Int J Nanomedicine. 2023;18:1131\u201343. https:\/\/doi.org\/10.2147\/IJN.S400798.","journal-title":"Int J Nanomedicine"},{"key":"1837_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejpb.2012.11.021","volume":"84","author":"FC Carvalho","year":"2013","unstructured":"Carvalho FC, Campos ML, Peccinini RG, Gremi\u00e3o MPD. Nasal administration of liquid crystal precursor mucoadhesive vehicle as an alternative antiretroviral therapy. Eur J Pharm Biopharm. 2013;84:219\u201327. https:\/\/doi.org\/10.1016\/j.ejpb.2012.11.021.","journal-title":"Eur J Pharm Biopharm"},{"key":"1837_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"A Nair","year":"2016","unstructured":"Nair A, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27. https:\/\/doi.org\/10.4103\/0976-0105.177703.","journal-title":"J Basic Clin Pharm"},{"key":"1837_CR26","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jconrel.2022.11.051","volume":"353","author":"X Gao","year":"2023","unstructured":"Gao X, Xiong Y, Chen H, Gao X, Dai J, Zhang Y, et al. Mucus adhesion vs. mucus penetration? screening nanomaterials for nasal inhalation by MD simulation. J Controlled Release. 2023;353:366\u201379. https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.051.","journal-title":"J Controlled Release"},{"key":"1837_CR27","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1021\/bm501419z","volume":"15","author":"LM Ensign","year":"2014","unstructured":"Ensign LM, Lai SK, Wang Y-Y, Yang M, Mert O, Hanes J, et al. Pretreatment of human cervicovaginal mucus with pluronic F127 enhances nanoparticle penetration without compromising mucus barrier properties to herpes simplex virus. Biomacromol. 2014;15:4403\u20139. https:\/\/doi.org\/10.1021\/bm501419z.","journal-title":"Biomacromol"},{"key":"1837_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071706","volume":"10","author":"R Boyuklieva","year":"2022","unstructured":"Boyuklieva R, Pilicheva B. Micro- and nanosized carriers for nose-to-brain drug delivery in neurodegenerative disorders. Biomedicines. 2022;10: 1706. https:\/\/doi.org\/10.3390\/biomedicines10071706.","journal-title":"Biomedicines"},{"key":"1837_CR29","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1021\/acs.molpharmaceut.1c00366","volume":"18","author":"AR Clementino","year":"2021","unstructured":"Clementino AR, Pellegrini G, Banella S, Colombo G, Cant\u00f9 L, Sonvico F, et al. Structure and fate of nanoparticles designed for the nasal delivery of poorly soluble drugs. Mol Pharm. 2021;18:3132\u201346. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00366.","journal-title":"Mol Pharm"},{"key":"1837_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.colsurfb.2017.03.035","volume":"154","author":"A Bonaccorso","year":"2017","unstructured":"Bonaccorso A, Musumeci T, Serapide MF, Pellitteri R, Uchegbu IF, Puglisi G. Nose to brain delivery in rats: effect of surface charge of rhodamine B labeled nanocarriers on brain subregion localization. Colloids Surf B Biointerfaces. 2017;154:297\u2013306. https:\/\/doi.org\/10.1016\/j.colsurfb.2017.03.035.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1837_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ph16081055","volume":"16","author":"SH Peczek","year":"2023","unstructured":"Peczek SH, Tartari APS, Zittlau IC, Diedrich C, Machado CS, Mainardes RM. Enhancing oral bioavailability and brain biodistribution of perillyl alcohol using nanostructured lipid carriers. Pharmaceuticals. 2023;16: 1055. https:\/\/doi.org\/10.3390\/ph16081055.","journal-title":"Pharmaceuticals"},{"key":"1837_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jconrel.2020.03.009","volume":"322","author":"X Gu","year":"2020","unstructured":"Gu X, Song Q, Zhang Q, Huang M, Zheng M, Chen J, et al. Clearance of two organic nanoparticles from the brain via the paravascular pathway. J Controlled Release. 2020;322:31\u201341. https:\/\/doi.org\/10.1016\/j.jconrel.2020.03.009.","journal-title":"J Controlled Release"},{"key":"1837_CR33","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.bbamem.2017.02.008","volume":"1859","author":"A Korytowski","year":"2017","unstructured":"Korytowski A, Abuillan W, Amadei F, Makky A, Gumiero A, Sinning I, et al. Accumulation of phosphatidylcholine on gut mucosal surface is not dominated by electrostatic interactions. Biochim Biophys Acta BBA - Biomembr. 2017;1859:959\u201365. https:\/\/doi.org\/10.1016\/j.bbamem.2017.02.008.","journal-title":"Biochim Biophys Acta BBA - Biomembr"},{"key":"1837_CR34","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1021\/acs.molpharmaceut.3c00639","volume":"21","author":"A Maaz","year":"2024","unstructured":"Maaz A, Blagbrough IS, De Bank PA. A cell-based nasal model for screening the deposition, biocompatibility, and transport of aerosolized PLGA nanoparticles. Mol Pharm. 2024;21:1108\u201324. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00639.","journal-title":"Mol Pharm"},{"key":"1837_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtcomm.2020.101692","volume":"25","author":"R Augustine","year":"2020","unstructured":"Augustine R, Hasan A, Primavera R, Wilson RJ, Thakor AS, Kevadiya BD. Cellular uptake and retention of nanoparticles: insights on particle properties and interaction with cellular components. Mater Today Commun. 2020;25: 101692. https:\/\/doi.org\/10.1016\/j.mtcomm.2020.101692.","journal-title":"Mater Today Commun"},{"key":"1837_CR36","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1039\/D0CS01127D","volume":"50","author":"M Sousa De Almeida","year":"2021","unstructured":"Sousa De Almeida M, Susnik E, Drasler B, Taladriz-Blanco P, Petri-Fink A, Rothen-Rutishauser B. Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine. Chem Soc Rev. 2021;50:5397\u2013434. https:\/\/doi.org\/10.1039\/D0CS01127D.","journal-title":"Chem Soc Rev"},{"key":"1837_CR37","doi-asserted-by":"publisher","first-page":"1900123","DOI":"10.1002\/adbi.201900123","volume":"3","author":"M Kumarasamy","year":"2019","unstructured":"Kumarasamy M, Sosnik A. The Nose-to-brain transport of polymeric nanoparticles is mediated by immune sentinels and not by olfactory sensory neurons. Adv Biosyst. 2019;3:1900123. https:\/\/doi.org\/10.1002\/adbi.201900123.","journal-title":"Adv Biosyst"},{"key":"1837_CR38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41565-023-01551-8","volume":"19","author":"J Gao","year":"2024","unstructured":"Gao J, Song Q, Gu X, Jiang G, Huang J, Tang Y, et al. Intracerebral fate of organic and inorganic nanoparticles is dependent on microglial extracellular vesicle function. Nat Nanotechnol. 2024;19:376\u201386. https:\/\/doi.org\/10.1038\/s41565-023-01551-8.","journal-title":"Nat Nanotechnol"},{"key":"1837_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.729706","volume":"15","author":"J Liu","year":"2022","unstructured":"Liu J, Guo Y, Zhang C, Zeng Y, Luo Y, Wang G. Clearance systems in the brain, from structure to function. Front Cell Neurosci. 2022;15: 729706. https:\/\/doi.org\/10.3389\/fncel.2021.729706.","journal-title":"Front Cell Neurosci"},{"key":"1837_CR40","doi-asserted-by":"publisher","first-page":"6351","DOI":"10.1038\/s41598-021-85293-4","volume":"11","author":"G Nehra","year":"2021","unstructured":"Nehra G, Andrews S, Rettig J, Gould MN, Haag JD, Howard SP, et al. Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats. Sci Rep. 2021;11:6351. https:\/\/doi.org\/10.1038\/s41598-021-85293-4.","journal-title":"Sci Rep"},{"key":"1837_CR41","doi-asserted-by":"publisher","first-page":"CASE22215","DOI":"10.3171\/CASE22215","volume":"4","author":"AH Sch\u00f6nthal","year":"2022","unstructured":"Sch\u00f6nthal AH, Swenson S, Bonney PA, Wagle N, Simmon VF, Mathew AJ, et al. Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative case. J Neurosurg Case Lessons. 2022;4:CASE22215. https:\/\/doi.org\/10.3171\/CASE22215.","journal-title":"J Neurosurg Case Lessons"},{"key":"1837_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-015-0374-5","volume":"14","author":"DG Garcia","year":"2015","unstructured":"Garcia DG, Castro-Faria-Neto HCD, Silva CID, Souza E Souza KFCD, Gon\u00e7alves-de-Albuquerque CF, Silva AR, et al. Na\/K-ATPase as a target for anticancer drugs: studies with perillyl alcohol. Mol Cancer. 2015;14:105. https:\/\/doi.org\/10.1186\/s12943-015-0374-5.","journal-title":"Mol Cancer"},{"key":"1837_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ejpb.2020.06.010","volume":"153","author":"FD Victorelli","year":"2020","unstructured":"Victorelli FD, Cardoso VMDO, Ferreira NN, Calixto GMF, Fontana CR, Baltazar F, et al. Chick embryo chorioallantoic membrane as a suitable in vivo model to evaluate drug delivery systems for cancer treatment: a review. Eur J Pharm Biopharm. 2020;153:273\u201384. https:\/\/doi.org\/10.1016\/j.ejpb.2020.06.010.","journal-title":"Eur J Pharm Biopharm"},{"key":"1837_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100570","volume":"19","author":"K Mitrevska","year":"2023","unstructured":"Mitrevska K, Merlos Rodrigo MA, Cernei N, Michalkova H, Splichal Z, Hynek D, et al. Chick chorioallantoic membrane (CAM) assay for the evaluation of the antitumor and antimetastatic activity of platinum-based drugs in association with the impact on the amino acid metabolism. Mater Today Bio. 2023;19: 100570. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100570.","journal-title":"Mater Today Bio"},{"key":"1837_CR45","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s13346-020-00713-8","volume":"10","author":"NN Ferreira","year":"2020","unstructured":"Ferreira NN, Granja S, Boni FI, Ferreira LMB, Reis RM, Baltazar F, et al. A novel strategy for glioblastoma treatment combining alpha-cyano-4-hydroxycinnamic acid with cetuximab using nanotechnology-based delivery systems. Drug Deliv Transl Res. 2020;10:594\u2013609. https:\/\/doi.org\/10.1007\/s13346-020-00713-8.","journal-title":"Drug Deliv Transl Res"},{"key":"1837_CR46","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s13346-020-00824-2","volume":"10","author":"NN Ferreira","year":"2020","unstructured":"Ferreira NN, Granja S, Boni FI, Prezotti FG, Ferreira LMB, Cury BSF, et al. Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route. Drug Deliv Transl Res. 2020;10:1729\u201347. https:\/\/doi.org\/10.1007\/s13346-020-00824-2.","journal-title":"Drug Deliv Transl Res"},{"key":"1837_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/0261192919856806","volume":"47","author":"RI De \u00c1vila","year":"2019","unstructured":"De \u00c1vila RI, Valadares MC. Brazil moves toward the replacement of animal experimentation. Altern Lab Anim. 2019;47:71\u201381. https:\/\/doi.org\/10.1177\/0261192919856806.","journal-title":"Altern Lab Anim"},{"key":"1837_CR48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00005-008-0027-0","volume":"56","author":"COD Fonseca","year":"2008","unstructured":"Fonseca COD, Linden R, Futuro D, Gattass CR, Quirico-Santos T. Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol. Arch Immunol Ther Exp (Warsz). 2008;56:267\u201376. https:\/\/doi.org\/10.1007\/s00005-008-0027-0.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"1837_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19123905","volume":"19","author":"TC Chen","year":"2018","unstructured":"Chen TC, Da Fonseca CO, Sch\u00f6nthal AH. Intranasal perillyl alcohol for glioma therapy: molecular mechanisms and clinical development. Int J Mol Sci. 2018;19: 3905. https:\/\/doi.org\/10.3390\/ijms19123905.","journal-title":"Int J Mol Sci"},{"key":"1837_CR50","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/jphp.12740","volume":"69","author":"A Kaffashi","year":"2017","unstructured":"Kaffashi A, L\u00fcle S, Bozda\u011f Pehlivan S, Sar\u0131s\u00f6zen C, Vural \u0130, Ko\u015fucu H, et al. Farnesylthiosalicylic acid-loaded lipid\u2013polyethylene glycol\u2013polymer hybrid nanoparticles for treatment of glioblastoma. J Pharm Pharmacol. 2017;69:1010\u201321. https:\/\/doi.org\/10.1111\/jphp.12740.","journal-title":"J Pharm Pharmacol"},{"key":"1837_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091919","volume":"14","author":"T Yang","year":"2022","unstructured":"Yang T, Zhai J, Hu D, Yang R, Wang G, Li Y, et al. \u201cTargeting design\u201d of nanoparticles in tumor therapy. Pharmaceutics. 2022;14: 1919. https:\/\/doi.org\/10.3390\/pharmaceutics14091919.","journal-title":"Pharmaceutics"},{"key":"1837_CR52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.nantod.2016.04.008","volume":"11","author":"H-X Wang","year":"2016","unstructured":"Wang H-X, Zuo Z-Q, Du J-Z, Wang Y-C, Sun R, Cao Z-T, et al. Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines. Nano Today. 2016;11:133\u201344. https:\/\/doi.org\/10.1016\/j.nantod.2016.04.008.","journal-title":"Nano Today"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01837-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01837-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01837-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:57:26Z","timestamp":1788353846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01837-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1837"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01837-5","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"4 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All in vivo studies were approved by the Federal University of Goi\u00e1s (UFG) Animal Research Ethics Committee Protocol 48\/21. Experimental protocols followed the principles for laboratory animal care and the Brazilian legislation (Law 11794, October 8, 2008). All institutional and national guidelines for the care and use of laboratory animals were followed.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. Research does not involve human subjects.","order":2,"name":"Ethics","label":"Ethics approval\/ consent to participate\/consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}